APA (7th ed.) Citation

Gonzalez-Juanatey, C., Vazquez-Rodriguez, T. R., Miranda-Filloy, J. A., Gomez-Acebo, I., Testa, A., Garcia-Porrua, C., . . . González-Gay, M. A. Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy. Wiley.

Chicago Style (17th ed.) Citation

Gonzalez-Juanatey, Carlos, Tomas R. Vazquez-Rodriguez, Jose A. Miranda-Filloy, Ines Gomez-Acebo, Ana Testa, Carlos Garcia-Porrua, Amalia Sanchez-Andrade, Javier Llorca, and Miguel A. González-Gay. Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy. Wiley.

MLA (9th ed.) Citation

Gonzalez-Juanatey, Carlos, et al. Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy. Wiley.